Working... Menu

A Biomarker Study to Evaluate MN-166 (Ibudilast) in Subjects With Amyotrophic Literal Sclerosis (ALS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02714036
Recruitment Status : Active, not recruiting
First Posted : March 21, 2016
Last Update Posted : July 20, 2018
Massachusetts General Hospital
South Shore Neurologic Associates
Information provided by (Responsible Party):

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : June 28, 2018
  Estimated Study Completion Date : April 2019